2022
Antarctic soil bacteria – unprecedented potential to produce novel secondary metabolites
BEZDÍČEK KRÁLOVÁ, Stanislava, Songcan CHEN, Mathias FLIEDER, Peter ŠPAČEK, Matěj BEZDÍČEK et. al.Základní údaje
Originální název
Antarctic soil bacteria – unprecedented potential to produce novel secondary metabolites
Autoři
BEZDÍČEK KRÁLOVÁ, Stanislava (703 Slovensko, garant, domácí), Songcan CHEN (156 Čína), Mathias FLIEDER (40 Rakousko), Peter ŠPAČEK (703 Slovensko), Matěj BEZDÍČEK (203 Česká republika), Jana HANSLIKOVÁ (203 Česká republika), Martin ZEHL (40 Rakousko), Sergey ZOTCHEV (643 Rusko), Thomas RATTEI (276 Německo) a Alexander LOY (276 Německo)
Vydání
29th Congress of the CSSM, 2022
Další údaje
Jazyk
angličtina
Typ výsledku
Prezentace na konferencích
Obor
10606 Microbiology
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Kód RIV
RIV/00216224:14310/22:00132597
Organizační jednotka
Přírodovědecká fakulta
Klíčová slova česky
Antarktida; biosynteticky potencial; antimikrobiální látky; rezistence
Klíčová slova anglicky
Antarctica; biosynthetic potential; antimicrobial compounds; resistance
Změněno: 20. 12. 2023 09:44, RNDr. Stanislava Bezdíček Králová, Ph.D.
Anotace
V originále
Discovering novel antimicrobial compounds is one of the priorities of current and future medicine in response to increasing levels of multidrug-resistant pathogens. The vast majority of antimicrobials is derived from microbes. Recent years of antimicrobial research showed that extreme habitats and unexplored or yet uncultivated microorganisms dwelling there might represent the most promising sources of novel antimicrobials. This study, which is linked to the MetaBac platform at the University of Vienna, aims to explore Antarctic soil bacterial isolates as a source of novel natural products with antimicrobial activities. Multiple isolation methods have been applied to obtain pure cultures of novel taxa from Antarctic soils; with focus on taxa known for their remarkable secondary metabolite biosynthesis potential. Initial stages of this research aimed to taxonomically classify all isolates and evaluate their biosynthetic potential. As a result, a collection of 623, mostly slow growing isolates was established. More than 60% of these strains belonged to the phyla Actinobacteriota and Bacillota, including several novel species (Streptomyces, Nocardioides, Dietzia, Paenibacillus). Pseudomonadota was the next most abundant group in the strain collection. Current steps based on these results include experiments with representatives of several novel Streptomyces spp. including cultivation in different conditions along with analysis of their metabolomes and immediate evaluation of antimicrobial activities against clinically relevant yeasts, gram-negative and gram-positive bacteria.
Návaznosti
LM2015078, projekt VaV |
|